The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.
Open accessAbstract
Idiopathic Parkinson's disease (PD) is a devastating movement disorder characterized by selective degeneration of the nigrostriatal dopaminergic pathway. Neurodegeneration usually starts in the fifth decade of life and progresses over 5-10 years before reaching the fully symptomatic disease state. Despite decades of intense research, the etiology of sporadic PD and the mechanism underlying the selective neuronal loss remain unknown. However, the late onset and slow-progressing nature of the disease has prompted the consideration of environmental exposure to agrochemicals, including pesticides, as a risk factor. Moreover, increasing evidence suggests that early-life occurrence of inflammation in the brain, as a consequence of either brain injury or exposure to infectious agents, may play a role in the pathogenesis of PD. Most important, there may be a self-propelling cycle of inflammatory process involving brain immune cells (microglia and astrocytes) that drives the slow yet progressive neurodegenerative process. Deciphering the molecular and cellular mechanisms governing those intricate interactions would significantly advance our understanding of the etiology and pathogenesis of PD and aid the development of therapeutic strategies for the treatment of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Babior, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,134
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Trophic factors and neuronal survival
Barde, Y.-A. (1989) · Neuron · doi:10.1016/0896-6273(89)90040-8 · Cited by 1,625
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Characterization of ameboid microglia isolated from developing mammalian brain
Giulian, D., & Baker, T. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02163.1986 · Cited by 1,313
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., & Peterson, P. K. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2736 · Cited by 1,136
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Self-citationMogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Functional plasticity of microglia: A review
Streit, W. J., Graeber, M. B., & Kreutzberg, G. W. (1988) · Glia · doi:10.1002/glia.440010502 · Cited by 940
Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias
Plassman, B. L., Havlik, R. J., Steffens, D. C., Helms, M. J., Newman, T. N., Drosdick, D., Phillips, C., Gau, B. A., Welsh–Bohmer, K. A., Burke, J. R., et al. (2000) · Neurology · doi:10.1212/wnl.55.8.1158 · Cited by 896
Kim, W.-G., Mohney, R. P., Wilson, B., Jeohn, G.-H., Liu, B., & Hong, J.-S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 878
Self-citationInterleukin 1 of the central nervous system is produced by ameboid microglia.
Giulian, D., Baker, T. J., Shih, L. C., & Lachman, L. B. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.2.594 · Cited by 859
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855
Raivich, G., Bohatschek, M., Kloss, C. U. A., Werner, A., Jones, L. L., & Kreutzberg, G. W. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00007-7 · Cited by 844
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
Lee, S. C., Liu, W., Dickson, D. W., Brosnan, C. F., & Berman, J. W. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2659 · Cited by 801
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Neurotrophic factors: from molecule to man
Lindsay, R. M., Wiegand, S. J., Anthony Altar, C., & DiStefano, P. S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90099-x · Cited by 788
Fontana, A., Kristensen, F., Dubs, R., Gemsa, D., & Weber, E. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.6.2413 · Cited by 752
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
Self-citationUnderstanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Pathological implications of nitric oxide, superoxide and peroxynitrite formation
Beckman, J. S., & Crow, J. P. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210330 · Cited by 673
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., & Richardson, R. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 639
Origin and functional consequences of the complex I defect in Parkinson's disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638
Production of tumor necrosis factor-alpha by microglia and astrocytes in culture
Sawada, M., Kondo, N., Suzumura, A., & Marunouchi, T. (1989) · Brain Research · doi:10.1016/0006-8993(89)90078-4 · Cited by 631
Environmental risk factors and Parkinson's disease: A case‐control study in Taiwan
Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., & Chen, R. C. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
Alam, M., & Schmidt, W. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00180-8 · Cited by 473
Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slechta, D. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
Parkinson's disease and exposure to agricultural work and pesticide chemicals
Semchuk, K. M., Love, E. J., & Lee, R. G. (1992) · Neurology · doi:10.1212/wnl.42.7.1328 · Cited by 439
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Self-citationSeidler, A., Hellenbrand, W., Robra, B.-P., Vieregge, P., Nischan, P., Joerg, J., Oertel, W. H., Ulm, G., & Schneider, E. (1996) · Neurology · doi:10.1212/wnl.46.5.1275 · Cited by 433
Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration
LIU, B., GAO, H., WANG, J., JEOHN, G., COOPER, C. L., & HONG, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04077.x · Cited by 425
Self-citationParaquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
CD200 and membrane protein interactions in the control of myeloid cells
Barclay, A. N., Wright, G. J., Brooke, G., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 416
Chao, C. C., Hu, S. X., Ehrlich, L., & Peterson, P. K. (1995) · Brain, Behavior, and Immunity · doi:10.1006/brbi.1995.1033 · Cited by 413
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 390
Graeber, M. B., Streit, W. J., & Kreutzberg, G. W. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490210104 · Cited by 367
Parkinson's disease and brain levels of organochlorine pesticides
Fleming, L., Mann, J. B., Bean, J., Briggle, T., & Sanchez‐Ramos, J. R. (1994) · Annals of Neurology · doi:10.1002/ana.410360119 · Cited by 352
Uversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02597-2 · Cited by 350
Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · cited 5×
“2001), and reactive oxygen species (ROS) such as superoxide anions (Gao et al. 2002a, 2002b; Liu et al. 2000a; Qin et al. 2002; Xie et al. 2002).”
BackgroundMethodInfluentialSelf-citationShohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben-Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01533.x · Cited by 331
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324
Colony-stimulating factors as promoters of ameboid microglia
Giulian, D., & Ingeman, J. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04707.1988 · Cited by 323
Control of glial immune function by neurons
Neumann, H. (2001) · Glia · doi:10.1002/glia.1108 · Cited by 319
Selective microglial activation in the rat rotenone model of Parkinson's disease
Sherer, T. B., Betarbet, R., Kim, J.-H., & Greenamyre, J. T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00172-1 · Cited by 316
Heikkila, R. E., Nicklas, W. J., Vyas, I., & Duvoisin, R. C. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90580-4 · Cited by 300
Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B., & Hong, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01210.x · Cited by 292
Self-citationFormation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 291
Brain macrophages synthesize interleukin‐1 and interleukin‐1 mRNAs in vitro
Hetier, E., Ayala, J., Denèfle, P., Bousseau, A., Rouget, P., Mallat, M., & Prochiantz, A. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490210230 · Cited by 287
The microglial cell. A historical review
Barron, K. D. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00209-k · Cited by 280
Risk factors for Parkinson's disease
Hubble, J. P., Cao, T., Hassanein, R. E. S., Neuberger, J. S., & Roller, W. C. (1993) · Neurology · doi:10.1212/wnl.43.9.1693 · Cited by 275
Xie, Z., Wei, M., Morgan, T. E., Fabrizio, P., Han, D., Finch, C. E., & Longo, V. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03484.2002 · Cited by 272
Epidemiology of Parkinson’s Disease
(2007) · Parkinson's Disease · doi:10.3109/9781420019223-6 · Cited by 262
Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication
Ferraz, H. B., F. Bertolucci, P. H., Pereira, J. S., Lima, J. G. C., & F. Andrade, L. A. (1988) · Neurology · doi:10.1212/wnl.38.4.550 · Cited by 260
. Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J., & Son, J. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00096.x · Cited by 256
Milligan, C. E., Cunningham, T. J., & Levitt, P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903140112 · Cited by 252
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01228.2003 · Cited by 251
Self-citationORGANOCHLORINE INSECTICIDES IN SUBSTANTIA NIGRA IN PARKINSON'S DISEASE
F.M. Corrigan, C. L. W. (2000) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/009841000156907 · Cited by 251
Mitochondrial dysfunction in Parkinson's disease
Greenamyre, J. T., MacKenzie, G., Peng, T.-I., & Stephans, S. E. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660085 · Cited by 248
Iravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247
Neurotoxicity of polychlorinated biphenyls: Structure-activity relationship of individual congeners
Shain, W., Bush, B., & Seegal, R. (1991) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(91)90131-w · Cited by 246
Dawson, V. L., Brahmbhatt, H. P., Mong, J. A., & Dawson, T. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90045-0 · Cited by 243
Ling, Z., Gayle, D. A., Ma, S. Y., Lipton, J. W., Tong, C. W., Hong, J., & Carvey, P. M. (2002) · Movement Disorders · doi:10.1002/mds.10078 · Cited by 241
Self-citationZhang, J., Fitsanakis, V. A., Gu, G., Jing, D., Ao, M., Amarnath, V., & Montine, T. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01525.x · Cited by 237
Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Acta Neuropathologica · doi:10.1007/bf00427222 · Cited by 231
Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons
McGuire, S. O., Ling, Z. D., Lipton, J. W., Sortwell, C. E., Collier, T. J., & Carvey, P. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7688 · Cited by 222
Developmental Exposure to the Pesticides Paraquat and Maneb and the Parkinson’s Disease Phenotype
Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., & Cory-Slechta, D. A. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00092-x · Cited by 214
Treatment of Parkinson's disease: levodopa as the first choice
Katzenschlager, R., & Lees, A. J. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1204-4 · Cited by 209
SEEGAL, R. (1990) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(90)90113-9 · Cited by 206
Pathology of Parkinson's Disease
(2006) · Understanding Parkinson's Disease · doi:10.5040/9798216029700.0007 · Cited by 206
Ferrante, R. J., Schulz, J. B., Kowall, N. W., & Beal, M. F. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00008-5 · Cited by 203
Parkinson's disease mortality and pesticide exposure in California 1984–1994
Ritz, B., & Yu, F. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.2.323 · Cited by 203
Gayle, D. A., Ling, Z., Tong, C., Landers, T., Lipton, J. W., & Carvey, P. M. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00315-7 · Cited by 200
Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate).
Meco, G., Bonifati, V, Vanacore, N., & Fabrizio, E. (1994) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.1394 · Cited by 200
Inflammation in Parkinson's disease.
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2001) · PubMed · Cited by 197
Müller, T., Blum-Degen, D., Przuntek, H., & Kuhn, W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb01736.x · Cited by 195
Jeohn, G.-H., Kong, L.-Y., Wilson, B., Hudson, P., & Hong, J.-S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00204-x · Cited by 186
Self-citationKitazawa, M., Anantharam, V., & Kanthasamy, A. G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00726-2 · Cited by 186
Plantation Work and Risk of Parkinson Disease in a Population-Based Longitudinal Study
Petrovitch, H., Ross, G. W., Abbott, R. D., Sanderson, W. T., Sharp, D. S., Tanner, C. M., Masaki, K. H., Blanchette, P. L., Popper, J. S., Foley, D., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1787 · Cited by 185
Taylor, C. A., Saint‐Hilaire, M. H., Cupples, L. A., Thomas, C. A., Burchard, A. E., Feldman, R. G., & Myers, R. H. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991215)88:6<742::aid-ajmg29>3.0.co;2-# · Cited by 179
Minghetti, L., & Levi, G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062690.x · Cited by 178
Diorthosubstituted Polychlorinated Biphenyls in Caudate Nucleus in Parkinson's Disease
Corrigan, F. M., Murray, L., Wyatt, C. L., & Shore, R. F. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6776 · Cited by 169
L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent
Hornykiewicz, O. (2002) · Amino Acids · doi:10.1007/s00726-001-0111-9 · Cited by 168
Liu, B., Jiang, J.-W., Wilson, B. C., Du, L., Yang, S.-N., Wang, J.-Y., Wu, G.-C., Cao, X.-D., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38877-9 · Cited by 167
Self-citationVernodokis, A. (1988) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60049-5 · Cited by 159
Downen, M., Amaral, T. D., Hua, L. L., Zhao, M., & Lee, S. C. (1999) · Glia · doi:10.1002/(sici)1098-1136(199911)28:2<114::aid-glia3>3.0.co;2-o · Cited by 158
The Role of Microglia and Astrocytes in Cns Immune Surveillance and Immunopathology
Aloisi, F. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4685-6_10 · Cited by 157
Williams, D. B., Annegers, J. F., Kokmen, E., O'Brien, P. C., & Kurland, L. T. (1991) · Neurology · doi:10.1212/wnl.41.10.1554 · Cited by 149
Does This Patient Have Parkinson Disease?
Rao, G., Fisch, L., Srinivasan, S., D'Amico, F., Okada, T., Eaton, C., & Robbins, C. W. (2003) · JAMA · doi:10.1001/jama.289.3.347 · Cited by 148
CYTOKINE-MEDIATED NEURONAL APOPTOSIS
Hu, S., Peterson, P. K., & Chao, C. C. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00078-2 · Cited by 147
Increased striatal dopamine turnover following acute administration of rotenone to mice
Thiffault, C., Langston, J. W., & Monte, D. A. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02960-7 · Cited by 143
Ageing and the nigrostriatal dopaminergic system
Reeves, S., Bench, C. J., & Howard, R. J. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.606 · Cited by 140
Gwinn, K. A. (2002) · Movement Disorders · doi:10.1002/mds.10173 · Cited by 139
The Epidemiology of Parkinson's Disease: A Case-Control Study of Young-Onset and Old-Onset Patients
Stern, M., Dulaney, E., Gruber, S. B., Golbe, L., Bergen, M., Hurtig, H., Gollomp, S., & Stolley, P. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530210029018 · Cited by 139
Stypuła, G., Radek, M., Stepien, H., Żylińska, K., & Pawlikowski, M. (1996) · NeuroImmunoModulation · doi:10.1159/000097237 · Cited by 134
Ladenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131
Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.
Tanner, C. M. (2003) · PubMed · Cited by 131
Acute and reversible parkinsonism due to organophosphate pesticide intoxication
Bhatt, M. H., Elias, M. A., & Mankodi, A. K. (1999) · Neurology · doi:10.1212/wnl.52.7.1467 · Cited by 131
Araki, E., Forster, C. L., Dubinsky, J. M., Ross, M. E., & Iadecola, C. (2001) · Stroke · doi:10.1161/hs1001.096057 · Cited by 128
Striatal Dopaminergic Pathways as a Target for the Insecticides Permethrin and Chlorpyrifos
Karen, D. J., Li, W., Harp, P. R., Gillette, J. S., & Bloomquist, J. R. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00063-8 · Cited by 125
Astrocytes in glutamate neurotransmission
Hansson, E., & Rönnbäck, L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7534736 · Cited by 124
The Epidemiology of Parkinson’s Disease in an Australian Population
McCann, S. J., Couteur, D. G. L., Green, A. C., Brayne, C., Johnson, A. G., Chan, D., McManus, M. E., & Pond, S. M. (1998) · Neuroepidemiology · doi:10.1159/000026185 · Cited by 124
Barbeau, A., Dallaire, L., Buu, N. T., Poirier, J., & Rucinska, E. J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90185-7 · Cited by 119
Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00300-2 · Cited by 118
Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease
Schulte, T., Schöls, L. J., Müller, T. H., Woitalla, D., Berger, K., & Krüger, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00301-4 · Cited by 117
The cellular pathology of Parkinson's disease
Takahashi, H., & Wakabayashi, K. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00403.x · Cited by 113
A rat model of Parkinson's disease induced by Japanese encephalitis virus.
Ogata, A., Tashiro, K., Nukuzuma, S., Nagashima, K., & Hall, W. (1997) · Journal of Neurovirology · doi:10.3109/13550289709015803 · Cited by 110
Parkinson’s Disease: Current and Future Challenges
Langston, J. W. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00098-0 · Cited by 109
Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis
Pradhan, S., Pandey, N., Shashank, S., Gupta, R. K., & Mathur, A. (1999) · Neurology · doi:10.1212/wnl.53.8.1781 · Cited by 108
Liou, H., Chen, R.-C., Tsai, Y.-F., Chen, W., Chang, Y.-C., & Tsai, M.-C. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0054 · Cited by 105
Toxicity of Dieldrin for Dopaminergic Neurons in Mesencephalic Cultures
Sanchez‐Ramos, J., Facca, A., Basit, A., & Song, S. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6770 · Cited by 105
Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease
Nishimura, M., Mizuta, I., Mizuta, E., Yamasaki, S., Ohta, M., & Kuno, S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00991-5 · Cited by 104
Parkinsonism and occupational exposure to pesticides
Engel, L. S., Checkoway, H., Keifer, M., Seixas, N. S., Longstreth, W. T., Scott, K. C., Hudnell, K., Anger, W. K., & Camicioli, R. M. (2001) · Occupational and Environmental Medicine · doi:10.1136/oem.58.9.582 · Cited by 103
Environmental risk factors of young onset Parkinson's disease: a case-control study
Tsai, C. H., Lo, S. K., See, L., Chen, H. Z., Chen, R., Weng, Y.-H., Chang, F., & Lu, C. (2002) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00027-6 · Cited by 102
L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice
Kohbata, S., & Beaman, B. L. (1991) · Infection and Immunity · doi:10.1128/iai.59.1.181-191.1991 · Cited by 102
Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides
Fitsanakis, V. A., Amarnath, V., Moore, J. T., Montine, K. S., Zhang, J., & Montine, T. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01169-3 · Cited by 100
Regulation of β‐nerve growth factor expression by inflammatory mediators in hippocampal cultures
Friedman, W., Lärkfors, L., Lièvre, C. A., Ebendal, T., Olson, L., & Persson, H. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270316 · Cited by 98
Neurological Sequelae of Boxing
Guterman, A., & SMITH, R. W. (1987) · Sports Medicine · doi:10.2165/00007256-198704030-00004 · Cited by 98
Neuronal Death: Is There a Role for Astrocytes?
Tacconi, M. T. (1998) · Neurochemical Research · doi:10.1023/a:1022463527474 · Cited by 97
Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity
Klegeris, A., & MCGEER, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00021-0 · Cited by 97
Friedrich Heinrich Lewy (1885?1950) and His Work
Holdorff, B. (2002) · Journal of the History of the Neurosciences · doi:10.1076/jhin.11.1.19.9106 · Cited by 96
Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease
Nishimura, M., Mizuta, I., Mizuta, E., Yamasaki, S., Ohta, M., Kaji, R., & Kuno, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02111-5 · Cited by 95
The genetics of Parkinson's disease
de Silva, H. R., Khan, N. L., & Wood, N. W. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00082-4 · Cited by 95
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease
Krüger, R., Hardt, C., Tschentscher, F., Jäckel, S., Kuhn, W., Müller, T., Werner, J., Woitalla, D., Berg, D., Kühnl, N., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070078 · Cited by 94
Lu, X., Bing, G., & Hagg, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00033-6 · Cited by 93
Kim, E. J., Kwon, K. J., Park, J., Lee, S., Moon, C., & Baik, E. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10373 · Cited by 90
Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993
Tüchsen, F., & Jensen, A. A. (2000) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.554 · Cited by 87
Microglial mitogens are produced in the developing and injured mammalian brain.
Giulian, D., Johnson, B., Krebs, J., George, J. K., & Tapscott, M. J. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.112.2.323 · Cited by 85
Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome
Charlett, A., Dobbs, R. J., Dobbs, S. M., Weller, C., Brady, P., & Peterson, D. W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00654.x · Cited by 82
Clinical aspects of Parkinson disease
Sethi, K. D. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00009 · Cited by 78
Trauma as an etiology of parkinsonism: A historical review of the concept
Factor, S. A., Sanchez‐Ramos, J., & Weiner, W. J. (1988) · Movement Disorders · doi:10.1002/mds.870030105 · Cited by 78
Choksi, N. Y., Kodavanti, P. R. S., Tilson, H. A., & Booth, R. G. (1997) · Toxicological Sciences · doi:10.1093/toxsci/39.1.76 · Cited by 72
Role and Mechanisms of Interleukin-1 in the Modulation of Neurotoxicity
Ma, X. C., Gottschall, P. E., Chen, L. T., Wiranowska, M., & Phelps, C. P. (2002) · NeuroImmunoModulation · doi:10.1159/000068322 · Cited by 72
Familial Parkinson's disease. Alpha-synuclein and parkin.
Mizuno, Y., Hattori, N., Kitada, T., Matsumine, H., Mori, H., Shimura, H., Kubo, S., Kobayashi, H., Asakawa, S., Minoshima, S., et al. (2001) · PubMed · Cited by 72
Chang, R. C. C., Hudson, P., Wilson, B., Haddon, L., & Hong, J.-S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02255-6 · Cited by 68
Chu, I. (1995) · Fundamental and Applied Toxicology · doi:10.1006/faat.1995.1099 · Cited by 68
Mariussen, E., Andersson, P. L., Tysklind, M., & Fonnum, F. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9231 · Cited by 67
Kostrzewa, R. M., Kostrzewa, J. P., & Brus, R. (2002) · Amino Acids · doi:10.1007/s00726-001-0110-x · Cited by 64
Earley, F. G. P., & RAGAN, C. I. (1984) · Biochemical Journal · doi:10.1042/bj2240525 · Cited by 63
Radical formation site of cerebral complex I and Parkinson's disease
Fukushima, T., Tawara, T., Lsobe, A., Hojo, N., Shiwaku, K., & Yamane, Y. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420313 · Cited by 62
Altschuler, E. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90223-6 · Cited by 60
Transient severe parkinsonism after acute organophosphate poisoning
KOLBE, H., Dengler, R., & Müller‐Vahl, K. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.253 · Cited by 58
Marey‐Semper, I., Gelman, M., & Lévi‐Strauss, M. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00955.x · Cited by 54
The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease
Diedrich, J. F., Wietgrefe, S. W., Zupancic, M., Staskus, K., Retzel, E. F., Haase, A. T., & Race, R. (1987) · Microbial Pathogenesis · doi:10.1016/0882-4010(87)90050-7 · Cited by 54
A Case-Control Study of Parkinson's Disease in Urban Population of Southern Israel
Herishanu, Y. O., Medvedovski, M., Goldsmith, J. R., & Kordysh, E. A. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100052835 · Cited by 54
Ott, W. R., Steinemann, A. C., & Wallace, L. A. (2006) · CRC Press eBooks · doi:10.1201/9781420012637-26 · Cited by 52
Parkinson's syndrome after closed head injury: a single case report
Doder, M., Jahanshahi, M., Turjanski, N., MOSELEY, I. F., & Lees, A. J. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.3.380 · Cited by 51
Parkinsonism: differential age‐trend in Helicobacter pylori antibody
Dobbs, S. M., Charlett, Dobbs, S. M., Weller, & Peterson, P. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00815.x · Cited by 49
Hubble, J. P., Cao, T., Kjelstrom, J. A., Koller, W. C., & Beaman, B. L. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2768-2769.1995 · Cited by 40
Jeohn, G., Kim, W.-G., & Hong, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02737-2 · Cited by 38
Self-citationSchwartz, J. L., & Elizan, T. S. (1979) · Annals of Neurology · doi:10.1002/ana.410060314 · Cited by 37
Nayernouri, T. (1985) · Surgical Neurology · doi:10.1016/0090-3019(85)90035-7 · Cited by 37
Behavior, neurochemistry and histology after intranigral lipopolysaccharide injection
Hsieh, P. F., Chia, L., Ni, D.-R., Cheng, L.-J., Ho, Y.-P., Tzeng, S., Chang, M.-H., & Hong, J. (2002) · Neuroreport · doi:10.1097/00001756-200203040-00006 · Cited by 36
Self-citationNucleic Acid Homology Studies of Viral Nucleic Acids in Idiopathic Parkinson's Disease
Wetmur, J. G., Schwartz, J., & Elizan, T. S. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500440032004 · Cited by 35
Tam, S. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8012 · Cited by 34
Dopaminergic substitution in Parkinson’s disease
Müller, T. H. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.10.1393 · Cited by 30
Bougria, M., Vitórica, J., Cano, J., & Machado, A. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90083-7 · Cited by 29
Art and artifice in the science of histology
RIO‐HORTEGA, P. D. (1993) · Histopathology · doi:10.1111/j.1365-2559.1993.tb00171.x · Cited by 28
Circulating antibody to Nocardia in the serum of patients with Parkinson's disease.
Kohbata, S., & Shimokawa, K. (1993) · PubMed · Cited by 26
Elizan, T., & Casals, J. (1991) · Journal of Neurological Sciences · doi:10.1016/0022-510x(91)90135-t · Cited by 25
Influenza and Mania: A Possible Connection With the Locus Ceruleus
MAURIZI, C. P. (1985) · Southern Medical Journal · doi:10.1097/00007611-198502000-00025 · Cited by 24
Experimental Studies on Kinetics and Functions of Monuclear Phagozytes of the Central Nervous System
Oehmichen, M., Grüninger, H., & Genčić, M. (1975) · Springer eBooks · doi:10.1007/978-3-662-08456-4_50 · Cited by 22
Alafiatayo, R., Cookson, M., & Pentreath, V. W. (1994) · Parasitology Research · doi:10.1007/bf00932678 · Cited by 21
Schiller, F. (2000) · Journal of the History of the Neurosciences · doi:10.1076/0964-704x(200008)9:2;1-y;ft148 · Cited by 21
Chang, R. C., Hudson, P. M., Wilson, B. C., Liu, B., Abel, H., Hemperly, J. J., & Hong, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00175-3 · Cited by 19
Self-citationInteractions of Nocardia asteroides with murine glia cells in culture
Beaman, L., & Beaman, B. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.343-347.1993 · Cited by 19
Clinical aspects of Parkinson disease
Sethi, K. D. (2003) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200302010-00004 · Cited by 11
Cited by
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Self-citationEpidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
“Although the microglial superoxide response is immediate, microglia also respond to LPS with a later pulse of pro-inflammatory factors, such as TNF- , IL-1 , and NO, both in vivo and in vitro.(65) Specifically, there is a delay in the production of TNF- , NO, prostaglandin E2 (PGE2), and interleukin (IL)-1 , in which…”
BackgroundTansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Role of Microglia in Central Nervous System Infections
Rock, R. B., Gekker, G., Hu, S., Sheng, W. S., Cheeran, M., Lokensgard, J. R., & Peterson, P. K. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.942-964.2004 · Cited by 723
Metadata
- Authors
- Liu, B., Gao, H.-M., & Hong, J.-S.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-06
- Volume
- 111
- Issue
- 8
- Pages
- 1065-1073
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2032247291
- Cited by
- 285
- References
- 180
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.